Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease
Status:
Completed
Trial end date:
2020-07-23
Target enrollment:
Participant gender:
Summary
ORCHID is a multicenter, blinded, placebo-controlled, randomized clinical trial evaluating
hydroxychloroquine for the treatment of adults hospitalized with COVID-19. Patients, treating
clinicians, and study personnel will all be blinded to study group assignment.